SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-16-108311
Filing Date
2016-03-29
Accepted
2016-03-29 16:48:09
Documents
6
Effectiveness Date
2016-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 a16-7295_1s8.htm S-8 207703
2 EX-5.1 a16-7295_1ex5d1.htm EX-5.1 20948
3 EX-23.1 a16-7295_1ex23d1.htm EX-23.1 2166
4 EX-99.2(A) a16-7295_1ex99d2a.htm EX-99.2(A) 264491
5 EX-99.3 a16-7295_1ex99d3.htm EX-99.3 97429
6 GRAPHIC g72951kei001.gif GRAPHIC 3053
  Complete submission text file 0001104659-16-108311.txt   598098
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-210456 | Film No.: 161535833
SIC: 2834 Pharmaceutical Preparations